CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway–altered
Abstract Diffuse low-grade glioma, MAPK pathway–altered (DLGG–MAPK), is a recently defined tumor entity characterized by genetic alterations activating the MAPK signaling cascade. While BRAF and FGFR alterations are most frequently reported, the biological and clinical significance of other MAPK-act...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2026-03-01
|
| סדרה: | Acta Neuropathologica Communications |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s40478-026-02271-5 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
